Oscar Health, Inc. $OSCR Shares Sold by US Bancorp DE

US Bancorp DE decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 84.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,088 shares of the company’s stock after selling 16,963 shares during the quarter. US Bancorp DE’s holdings in Oscar Health were worth $40,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of OSCR. Larson Financial Group LLC lifted its holdings in Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after purchasing an additional 2,512 shares during the period. CWM LLC lifted its holdings in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after purchasing an additional 1,078 shares during the period. Princeton Global Asset Management LLC acquired a new stake in Oscar Health in the first quarter worth about $59,000. GAMMA Investing LLC lifted its holdings in Oscar Health by 2,156.4% in the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company’s stock worth $85,000 after purchasing an additional 6,189 shares during the period. Finally, Tower Research Capital LLC TRC lifted its holdings in Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock worth $89,000 after purchasing an additional 4,185 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Price Performance

NYSE OSCR opened at $16.6390 on Wednesday. The stock’s 50-day moving average price is $16.02 and its two-hundred day moving average price is $14.80. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The company has a market cap of $4.30 billion, a PE ratio of -20.54 and a beta of 1.86. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business’s revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.20 EPS. On average, analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on OSCR. UBS Group reaffirmed a “sell” rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Robert W. Baird reissued a “neutral” rating and issued a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Piper Sandler cut their price target on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Barclays cut their price target on shares of Oscar Health from $17.00 to $11.00 and set an “underweight” rating for the company in a report on Wednesday, July 23rd. Finally, Baird R W downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, July 25th. Four investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Strong Sell” and a consensus target price of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.